Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangbingdu Oral Liquid for mild influenza A
ChiCTR-TRC-10000828Phase 4Suspended
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Xiangxue Antiviral Oral Liquid in Influenza A infection (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Time to alleviation of symptoms and Incidence of complication. Started Mar 2010; status: suspended.
02
Drugs
Xiangxue Antiviral Oral Liquid
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on ChiCTR-TRC-10000828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000828.